← FDA DRUG APPROVALS

FDA ANDA · ANDA078417

FOSPHENYTOIN SODIUM

Sponsor: SUN PHARM

APPLICATION
ANDA078417
TYPE
ANDA
ORIGINAL APPROVAL
2008-03-18
LATEST ACTION
2013-08-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FOSPHENYTOIN SODIUMPrescription
FOSPHENYTOIN SODIUM EQ 50MG PHENYTOIN NA/ML · INJECTABLE · INJECTION

Approval history

2013-08-21Labeling · Supplement 2 · standardAP
2008-03-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →